Pier Capital’s Abiomed Inc ABMD Stock Holding History

Pier Capital’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-32,664	Closed	-$3.03M	–	141
2015 Q3	$3.03M	Buy	+32,664	New	+$2.88M	0.49%	98

Other funds holding ABMD

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Pier Capital's ABMD Position: Q4 2015 in Review

Pier Capital sold out of Abiomed Inc (ABMD) in Q4 2015, closing a stake of 32,664 shares — an estimated $3.03M sold.

Pier Capital first reported a position in ABMD in Q3 2015 and held it in 1 quarter. The position peaked at $3.03M in Q3 2015. 249 funds tracked by Wall St. Rank hold ABMD as of Q4 2015.

Pier Capital reported no remaining Abiomed Inc position as of Q4 2015 after selling out during the quarter.
Pier Capital sold 32,664 Abiomed Inc shares in Q4 2015, an estimated $3.03M.
Pier Capital first reported a position in Abiomed Inc in Q3 2015 and held it in 1 quarter.
Pier Capital's Abiomed Inc position peaked at $3.03M in Q3 2015.
249 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2015.

Based on Pier Capital's 13F filing for Q4 2015, filed 12 Feb 2016.